相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents
Roger Bedimo et al.
AIDS (2012)
Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study
Ann-Brit E. Hansen et al.
AIDS (2012)
Higher Rates of Bone Loss in Postmenopausal HIV-Infected Women: A Longitudinal Study
Michael T. Yin et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Endocrine complications of human immunodeficiency virus infection: Hypogonadism, bone disease and tenofovir-related toxicity
Aoife G. Cotter et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Increased Rates of Bone Fracture among HIV-Infected Persons in the HIV Outpatient Study (HOPS) Compared with the US General Population, 2000-2006
Benjamin Young et al.
CLINICAL INFECTIOUS DISEASES (2011)
Stable Bone Density in HAART-Treated Individuals with HIV: A Meta-Analysis
Mark J. Bolland et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
Grace A. McComsey et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Increased Risk of Fragility Fractures among HIV Infected Compared to Uninfected Male Veterans
Julie A. Womack et al.
PLOS ONE (2011)
Bone Mineral Density in HIV-Negative Men Participating in a Tenofovir Pre-Exposure Prophylaxis Randomized Clinical Trial in San Francisco
Albert Y. Liu et al.
PLOS ONE (2011)
Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV
Jacqueline Neuhaus et al.
AIDS (2010)
Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study
Michael T. Yin et al.
AIDS (2010)
Comparison of Changes in Bone Density and Turnover with Abacavir-Lamivudine versus Tenofovir-Emtricitabine in HIV-Infected Adults: 48-Week Results from the ASSERT Study
Hans-Juergen Stellbrink et al.
CLINICAL INFECTIOUS DISEASES (2010)
Bone Disease in HIV Infection: A Practical Review and Recommendations for HIV Care Providers
Grace A. McComsey et al.
CLINICAL INFECTIOUS DISEASES (2010)
HIV and bone mineral density
Patrick W. G. Mallon
CURRENT OPINION IN INFECTIOUS DISEASES (2010)
Tenofovir-Linked Hyperparathyroidism Is Independently Associated With the Presence of Vitamin D Deficiency
Melanie M. Rosenvinge et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2010)
The diagnosis of osteoporosis
John A. Kanis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir
Marit G. A. van Vonderen et al.
AIDS (2009)
Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults
Fideline Collin et al.
AIDS (2009)
Continuous antiretroviral therapy decreases bone mineral density
Birgit Grund et al.
AIDS (2009)
A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis
Jeannie Huang et al.
AIDS (2009)
High Frequency of Vitamin D Deficiency in Ambulatory HIV-Positive Patients
M. Rodriguez et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2009)
Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: A Randomized, 96-Week Trial
Allison Martin et al.
CLINICAL INFECTIOUS DISEASES (2009)
Reduced bone mineral density in HIV-infected patients:: prevalence and associated factors
Charles Cazanave et al.
AIDS (2008)
Vitamin D Deficiency among HIV Type 1-Infected Individuals in the Netherlands: Effects of Antiretroviral Therapy
Carolien J. P. Van Den Bout-Van Den Beukel et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV
J. D. Lundgren et al.
HIV MEDICINE (2008)
Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large US healthcare system
Virginia A. Triant et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Risk factors for decreased bone density and effects of HIV on bone in the elderly
S. Jones et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Low body weight mediates the relationship between HIV infection and low bone mineral density: A meta-analysis
Mark J. Bolland et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV
Grace A. McComsey et al.
AIDS (2007)
Annual zoledronate increases bone density in highly active Antiretroviral therapy-treated human immunodeficiency virus-infected men: A randomized controlled trial
Mark J. Bolland et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection
Julia H. Arnsten et al.
AIDS (2007)
Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review
Todd T. Brown et al.
AIDS (2006)
Potential predictive factors of osteoporosis in HIV positive subjects
Alfonso Fausto et al.
BONE (2006)
Mechanisms of disease - Bone quality - The material and structural basis of bone strength and fragility
Ego Seeman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV
JE Gallant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Bone mass and mineral metabolism in HIV plus postmenopausal women
M Yin et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection
K Mondy et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
BMD is reduced in HIV-infected men irrespective of treatment
C Amiel et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Alendronate reduces bone resorption in HIV-associated osteopenia/osteoporosis
G Guaraldi et al.
HIV CLINICAL TRIALS (2004)
A meta-analysis of previous fracture and subsequent fracture risk
JA Kanis et al.
BONE (2004)
Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy
D Bruera et al.
AIDS (2003)
Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals
K Mondy et al.
CLINICAL INFECTIOUS DISEASES (2003)
Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy
A Carr et al.
AIDS (2001)
The osteoblast: A sophisticated fibroblast under central surveillance
P Ducy et al.
SCIENCE (2000)
分享论文
